APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology & Cancer Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oncology & Cancer Drugs Industry Growth and Trends Forecast to 2032

20 December 2025105 pages

Choose your research edition.

Industry ResearchOncology & Cancer Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology & Cancer Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Oncology & Cancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology & Cancer Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology & Cancer Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Oncology & Cancer Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oncology & Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oncology & Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology & Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology & Cancer Drugs include Sanofi, Novartis, Roche, Lunan, Eli Lilly and Company, GuiZhou YiBai, AstraZeneca, QILU and LUYE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oncology & Cancer Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncology & Cancer Drugs market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology & Cancer Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology & Cancer Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oncology & Cancer Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncology & Cancer Drugs Market by Company

Sanofi

Novartis

Roche

Lunan

Eli Lilly and Company

GuiZhou YiBai

AstraZeneca

QILU

LUYE

HENGRUI

HANSOH

Oncology & Cancer Drugs Segment by Type

Platinum-based drugs

Hormone

Antimetabolite

Alkaloid drugs

Targeted drug

Other

Oncology & Cancer Drugs Segment by Application

Blood Cancer

Gastrointestinal Cancer

Breast Cancer

Prostate Cancer

Respiratory/Lung Cancer

Other

Oncology & Cancer Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology & Cancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology & Cancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology & Cancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology & Cancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oncology & Cancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Platinum-based drugs Table 2. Major Company of Hormone Table 3. Major Company of Antimetabolite Table 4. Major Company of Alkaloid drugs Table 5. Major Company of Targeted drug Table 6. Major Company of Other Table 7. Global Oncology & Cancer Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Oncology & Cancer Drugs Sales by Type (2021-2026) & (k tons) Table 9. Global Oncology & Cancer Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Oncology & Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Oncology & Cancer Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Oncology & Cancer Drugs Price by Type (2021-2026) & (US$/ton) Table 13. Global Oncology & Cancer Drugs Sales by Type (2027-2032) & (k tons) Table 14. Global Oncology & Cancer Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Oncology & Cancer Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Oncology & Cancer Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Oncology & Cancer Drugs Price by Type (2027-2032) & (US$/ton) Table 18. North America Oncology & Cancer Drugs Sales by Type (2021-2026) & (k tons) Table 19. North America Oncology & Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Oncology & Cancer Drugs Sales by Type (2021-2026) & (k tons) Table 21. Europe Oncology & Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Oncology & Cancer Drugs Sales by Type (2021-2026) & (k tons) Table 23. Asia-Pacific Oncology & Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Oncology & Cancer Drugs Sales by Type (2021-2026) & (k tons) Table 25. Latin America Oncology & Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Oncology & Cancer Drugs Sales by Type (2021-2026) & (k tons) Table 27. Middle East and Africa Oncology & Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Oncology & Cancer Drugs Industry Trends Table 29. Oncology & Cancer Drugs Industry Drivers Table 30. Oncology & Cancer Drugs Industry Opportunities and Challenges Table 31. Oncology & Cancer Drugs Industry Restraints Table 32. Global Oncology & Cancer Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Oncology & Cancer Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Oncology & Cancer Drugs Sales by Company (2021-2026) & (k tons) Table 35. Global Oncology & Cancer Drugs Sales Share by Company (2021-2026) Table 36. Global Oncology & Cancer Drugs Market Price by Company (2021-2026) & (US$/ton) Table 37. Global Oncology & Cancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Oncology & Cancer Drugs Major Company Production Sites and Headquarters Table 39. Global Oncology & Cancer Drugs Company, Product Type & Application Table 40. Global Oncology & Cancer Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Oncology & Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Oncology & Cancer Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Oncology & Cancer Drugs Sales by Region (2021-2026) & (k tons) Table 45. Global Oncology & Cancer Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Oncology & Cancer Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Oncology & Cancer Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Oncology & Cancer Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 49. Global Oncology & Cancer Drugs Sales by Region (2027-2032) & (k tons) Table 50. Global Oncology & Cancer Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Oncology & Cancer Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Oncology & Cancer Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Oncology & Cancer Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 54. Global Oncology & Cancer Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Oncology & Cancer Drugs Sales by Application (2021-2026) & (k tons) Table 56. Global Oncology & Cancer Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Oncology & Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Oncology & Cancer Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Oncology & Cancer Drugs Price by Application (2021-2026) & (US$/ton) Table 60. Global Oncology & Cancer Drugs Sales by Application (2027-2032) & (k tons) Table 61. Global Oncology & Cancer Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Oncology & Cancer Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Oncology & Cancer Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Oncology & Cancer Drugs Price by Application (2027-2032) & (US$/ton) Table 65. North America Oncology & Cancer Drugs Sales by Application (2021-2026) & (k tons) Table 66. North America Oncology & Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Oncology & Cancer Drugs Sales by Application (2021-2026) & (k tons) Table 68. Europe Oncology & Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Oncology & Cancer Drugs Sales by Application (2021-2026) & (k tons) Table 70. Asia-Pacific Oncology & Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Oncology & Cancer Drugs Sales by Application (2021-2026) & (k tons) Table 72. Latin America Oncology & Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Oncology & Cancer Drugs Sales by Application (2021-2026) & (k tons) Table 74. Middle East and Africa Oncology & Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Sanofi Oncology & Cancer Drugs Product Portfolio Table 79. Sanofi Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Novartis Oncology & Cancer Drugs Product Portfolio Table 84. Novartis Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Roche Oncology & Cancer Drugs Product Portfolio Table 89. Roche Recent Development Table 90. Lunan Company Information Table 91. Lunan Business Overview Table 92. Lunan Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Lunan Oncology & Cancer Drugs Product Portfolio Table 94. Lunan Recent Development Table 95. Eli Lilly and Company Company Information Table 96. Eli Lilly and Company Business Overview Table 97. Eli Lilly and Company Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. Eli Lilly and Company Oncology & Cancer Drugs Product Portfolio Table 99. Eli Lilly and Company Recent Development Table 100. GuiZhou YiBai Company Information Table 101. GuiZhou YiBai Business Overview Table 102. GuiZhou YiBai Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. GuiZhou YiBai Oncology & Cancer Drugs Product Portfolio Table 104. GuiZhou YiBai Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. AstraZeneca Oncology & Cancer Drugs Product Portfolio Table 109. AstraZeneca Recent Development Table 110. QILU Company Information Table 111. QILU Business Overview Table 112. QILU Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. QILU Oncology & Cancer Drugs Product Portfolio Table 114. QILU Recent Development Table 115. LUYE Company Information Table 116. LUYE Business Overview Table 117. LUYE Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. LUYE Oncology & Cancer Drugs Product Portfolio Table 119. LUYE Recent Development Table 120. HENGRUI Company Information Table 121. HENGRUI Business Overview Table 122. HENGRUI Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 123. HENGRUI Oncology & Cancer Drugs Product Portfolio Table 124. HENGRUI Recent Development Table 125. HANSOH Company Information Table 126. HANSOH Business Overview Table 127. HANSOH Oncology & Cancer Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 128. HANSOH Oncology & Cancer Drugs Product Portfolio Table 129. HANSOH Recent Development Table 130. North America Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 131. North America Oncology & Cancer Drugs Sales by Country (2021-2026) & (k tons) Table 132. North America Oncology & Cancer Drugs Sales Market Share by Country (2021-2026) Table 133. North America Oncology & Cancer Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 134. North America Oncology & Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 135. North America Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America Oncology & Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 137. North America Oncology & Cancer Drugs Market Share by Country (2021-2026) Table 138. North America Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America Oncology & Cancer Drugs Market Share Forecast by Country (2027-2032) Table 140. Europe Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 141. Europe Oncology & Cancer Drugs Sales by Country (2021-2026) & (k tons) Table 142. Europe Oncology & Cancer Drugs Sales Market Share by Country (2021-2026) Table 143. Europe Oncology & Cancer Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 144. Europe Oncology & Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 145. Europe Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe Oncology & Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe Oncology & Cancer Drugs Market Share by Country (2021-2026) Table 148. Europe Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe Oncology & Cancer Drugs Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Oncology & Cancer Drugs Sales by Country (2021-2026) & (k tons) Table 152. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific Oncology & Cancer Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 154. Asia-Pacific Oncology & Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Oncology & Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific Oncology & Cancer Drugs Market Share by Country (2021-2026) Table 158. Asia-Pacific Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific Oncology & Cancer Drugs Market Share Forecast by Country (2027-2032) Table 160. Latin America Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 161. Latin America Oncology & Cancer Drugs Sales by Country (2021-2026) & (k tons) Table 162. Latin America Oncology & Cancer Drugs Sales Market Share by Country (2021-2026) Table 163. Latin America Oncology & Cancer Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 164. Latin America Oncology & Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America Oncology & Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America Oncology & Cancer Drugs Market Share by Country (2021-2026) Table 168. Latin America Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America Oncology & Cancer Drugs Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Oncology & Cancer Drugs Sales by Country (2021-2026) & (k tons) Table 172. Middle East and Africa Oncology & Cancer Drugs Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa Oncology & Cancer Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 174. Middle East and Africa Oncology & Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Oncology & Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa Oncology & Cancer Drugs Market Share by Country (2021-2026) Table 178. Middle East and Africa Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa Oncology & Cancer Drugs Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Oncology & Cancer Drugs Distributors List Table 183. Oncology & Cancer Drugs Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Oncology & Cancer Drugs Image Figure 2. Global Oncology & Cancer Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology & Cancer Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology & Cancer Drugs Sales (2021-2032) & (k tons) Figure 5. Platinum-based drugs Image Figure 6. Global Platinum-based drugs Sales YoY Growth (2021-2032) & (k tons) Figure 7. Hormone Image Figure 8. Global Hormone Sales YoY Growth (2021-2032) & (k tons) Figure 9. Antimetabolite Image Figure 10. Global Antimetabolite Sales YoY Growth (2021-2032) & (k tons) Figure 11. Alkaloid drugs Image Figure 12. Global Alkaloid drugs Sales YoY Growth (2021-2032) & (k tons) Figure 13. Targeted drug Image Figure 14. Global Targeted drug Sales YoY Growth (2021-2032) & (k tons) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (k tons) Figure 17. Global Oncology & Cancer Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Oncology & Cancer Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Oncology & Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Oncology & Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Oncology & Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Oncology & Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Oncology & Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Oncology & Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Oncology & Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Oncology & Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Oncology & Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Oncology & Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Oncology & Cancer Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Blood Cancer Image Figure 32. Global Blood Cancer Sales YoY Growth (2021-2032) & (k tons) Figure 33. Gastrointestinal Cancer Image Figure 34. Global Gastrointestinal Cancer Sales YoY Growth (2021-2032) & (k tons) Figure 35. Breast Cancer Image Figure 36. Global Breast Cancer Sales YoY Growth (2021-2032) & (k tons) Figure 37. Prostate Cancer Image Figure 38. Global Prostate Cancer Sales YoY Growth (2021-2032) & (k tons) Figure 39. Respiratory/Lung Cancer Image Figure 40. Global Respiratory/Lung Cancer Sales YoY Growth (2021-2032) & (k tons) Figure 41. Other Image Figure 42. Global Other Sales YoY Growth (2021-2032) & (k tons) Figure 43. Global Oncology & Cancer Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Oncology & Cancer Drugs Market Share by Application 2025 VS 2032 Figure 45. North America Oncology & Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 46. North America Oncology & Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 47. Europe Oncology & Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Europe Oncology & Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Oncology & Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Oncology & Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 51. Latin America Oncology & Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Oncology & Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Oncology & Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Oncology & Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 55. North America Oncology & Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. North America Oncology & Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Oncology & Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Oncology & Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Oncology & Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Europe Oncology & Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Oncology & Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Oncology & Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Oncology & Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 64. Asia-Pacific Oncology & Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Oncology & Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Oncology & Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Oncology & Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 68. Latin America Oncology & Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Oncology & Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Oncology & Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Oncology & Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 72. Middle East and Africa Oncology & Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Oncology & Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Oncology & Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Oncology & Cancer Drugs Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Oncology & Cancer Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Platinum-based drugs
  • Hormone
  • Antimetabolite
  • Alkaloid drugs
  • Targeted drug
  • Other
Applications
  • Blood Cancer
  • Gastrointestinal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Respiratory/Lung Cancer
  • Other
Companies covered
  • Sanofi
  • Novartis
  • Roche
  • Lunan
  • Eli Lilly and Company
  • GuiZhou YiBai
  • AstraZeneca
  • QILU
  • LUYE
  • HENGRUI
  • HANSOH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oncology & Cancer Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oncology & Cancer Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oncology & Cancer Drugs Market by Type
  6. 1.3.1 Platinum-based drugs
  7. 1.3.2 Hormone
  8. 1.3.3 Antimetabolite
  9. 1.3.4 Alkaloid drugs
  10. 1.3.5 Targeted drug
  11. 1.3.6 Other
  12. 1.4 Global Oncology & Cancer Drugs Market Size by Type
  13. 1.4.1 Global Oncology & Cancer Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Oncology & Cancer Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Oncology & Cancer Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Oncology & Cancer Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Oncology & Cancer Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Oncology & Cancer Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Oncology & Cancer Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Oncology & Cancer Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oncology & Cancer Drugs Industry Trends
  2. 2.2 Oncology & Cancer Drugs Industry Drivers
  3. 2.3 Oncology & Cancer Drugs Industry Opportunities and Challenges
  4. 2.4 Oncology & Cancer Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oncology & Cancer Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Oncology & Cancer Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Oncology & Cancer Drugs Price (2021-2026)
  4. 3.4 Global Oncology & Cancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology & Cancer Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Oncology & Cancer Drugs Company, Product Type & Application
  7. 3.7 Global Oncology & Cancer Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology & Cancer Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology & Cancer Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology & Cancer Drugs Tier 1, Tier 2, and Tier 3
4 Oncology & Cancer Drugs Regional Status and Outlook
  1. 4.1 Global Oncology & Cancer Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oncology & Cancer Drugs Historic Market Size by Region
  3. 4.2.1 Global Oncology & Cancer Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oncology & Cancer Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oncology & Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oncology & Cancer Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Oncology & Cancer Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oncology & Cancer Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oncology & Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oncology & Cancer Drugs by Application
  1. 5.1 Oncology & Cancer Drugs Market by Application
  2. 5.1.1 Blood Cancer
  3. 5.1.2 Gastrointestinal Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Prostate Cancer
  6. 5.1.5 Respiratory/Lung Cancer
  7. 5.1.6 Other
  8. 5.2 Global Oncology & Cancer Drugs Market Size by Application
  9. 5.2.1 Global Oncology & Cancer Drugs Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Oncology & Cancer Drugs Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Oncology & Cancer Drugs Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Oncology & Cancer Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Oncology & Cancer Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Oncology & Cancer Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Oncology & Cancer Drugs Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Oncology & Cancer Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Oncology & Cancer Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Oncology & Cancer Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Oncology & Cancer Drugs Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Lunan
  20. 6.4.1 Lunan Company Information
  21. 6.4.2 Lunan Business Overview
  22. 6.4.3 Lunan Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lunan Oncology & Cancer Drugs Product Portfolio
  24. 6.4.5 Lunan Recent Developments
  25. 6.5 Eli Lilly and Company
  26. 6.5.1 Eli Lilly and Company Company Information
  27. 6.5.2 Eli Lilly and Company Business Overview
  28. 6.5.3 Eli Lilly and Company Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly and Company Oncology & Cancer Drugs Product Portfolio
  30. 6.5.5 Eli Lilly and Company Recent Developments
  31. 6.6 GuiZhou YiBai
  32. 6.6.1 GuiZhou YiBai Company Information
  33. 6.6.2 GuiZhou YiBai Business Overview
  34. 6.6.3 GuiZhou YiBai Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GuiZhou YiBai Oncology & Cancer Drugs Product Portfolio
  36. 6.6.5 GuiZhou YiBai Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Oncology & Cancer Drugs Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 QILU
  44. 6.8.1 QILU Company Information
  45. 6.8.2 QILU Business Overview
  46. 6.8.3 QILU Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 QILU Oncology & Cancer Drugs Product Portfolio
  48. 6.8.5 QILU Recent Developments
  49. 6.9 LUYE
  50. 6.9.1 LUYE Company Information
  51. 6.9.2 LUYE Business Overview
  52. 6.9.3 LUYE Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 LUYE Oncology & Cancer Drugs Product Portfolio
  54. 6.9.5 LUYE Recent Developments
  55. 6.10 HENGRUI
  56. 6.10.1 HENGRUI Company Information
  57. 6.10.2 HENGRUI Business Overview
  58. 6.10.3 HENGRUI Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 HENGRUI Oncology & Cancer Drugs Product Portfolio
  60. 6.10.5 HENGRUI Recent Developments
  61. 6.11 HANSOH
  62. 6.11.1 HANSOH Company Information
  63. 6.11.2 HANSOH Business Overview
  64. 6.11.3 HANSOH Oncology & Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 HANSOH Oncology & Cancer Drugs Product Portfolio
  66. 6.11.5 HANSOH Recent Developments
7 North America by Country
  1. 7.1 North America Oncology & Cancer Drugs Sales by Country
  2. 7.1.1 North America Oncology & Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oncology & Cancer Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Oncology & Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oncology & Cancer Drugs Market Size by Country
  6. 7.2.1 North America Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oncology & Cancer Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oncology & Cancer Drugs Sales by Country
  2. 8.1.1 Europe Oncology & Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oncology & Cancer Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Oncology & Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oncology & Cancer Drugs Market Size by Country
  6. 8.2.1 Europe Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oncology & Cancer Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oncology & Cancer Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Oncology & Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oncology & Cancer Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oncology & Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oncology & Cancer Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oncology & Cancer Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oncology & Cancer Drugs Sales by Country
  2. 10.1.1 South America Oncology & Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oncology & Cancer Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Oncology & Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oncology & Cancer Drugs Market Size by Country
  6. 10.2.1 South America Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oncology & Cancer Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oncology & Cancer Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Oncology & Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oncology & Cancer Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oncology & Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oncology & Cancer Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Oncology & Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oncology & Cancer Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oncology & Cancer Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oncology & Cancer Drugs Value Chain Analysis
  2. 12.1.1 Oncology & Cancer Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oncology & Cancer Drugs Production Mode & Process
  7. 12.2 Oncology & Cancer Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oncology & Cancer Drugs Distributors
  10. 12.2.3 Oncology & Cancer Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst